Abbott Laboratories (ABT) has declared a quarterly dividend of $0.63 per share, payable to shareholders of record. This marks a 6.8% increase from the previous dividend of $0.59 per share.
The ex-dividend date is set for January 14, 2026, meaning investors must own shares before this date to qualify for the dividend. Payments will be issued on February 12, 2026.
The current dividend yield stands at 1.97%, reflecting the annual dividend income relative to the stock price. Abbott Laboratories, headquartered in Abbott Park, Illinois, employs 114,000 people and operates in the health care sector, with a market capitalization of $214.3 billion.
The company engages in the discovery, development, manufacture, and sale of a diverse range of healthcare products across various segments, including Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The upcoming earnings report is scheduled for July 15, 2026, with an estimated EPS of $1.40 and revenue expectations of $12.1 billion.
Such decisions reflect management's commitment to returning capital to shareholders while maintaining a strong financial position. Investors are encouraged to consider the company's dividend history, payout ratio, and overall financial health when assessing the sustainability of these payments.